Regardless of expanded legalization and utilization of healthcare cannabis (MC) internationally, there is a lack of patient-centered information on how MC is utilised by persons living with chronic situations in tandem with or as an alternative of prescription medicines. This study describes approaches to use of MC vis-à-vis prescription medicines in the therapy of chosen chronic situations.

Design and style:

Participants completed semistructured phone interviews with open-ended concerns. Content material evaluation of qualitative information identified themes and subthemes relating to patient approaches to employing MC merchandise.


Thirty persons (imply age = 44.six years) living with a variety of chronic situations (e.g., rheumatoid arthritis, Crohn’s illness, spinal cord injury/illness, and cancer) who had certified for and utilised MC in Illinois.


Participants described a variety of approaches to employing MC, which includes (1) as options to employing prescription or more than-the-counter medicines (two) complementary use with prescription medicines and (three) as a signifies for tapering off prescription medicines. Motives reported for decreasing or eliminating prescription medicines incorporated issues concerning toxicity, dependence, and tolerance, and perceptions that MC improves management of particular symptoms and has faster action and longer lasting effects.


MC seems to serve as each a complementary technique for symptom management and therapy of medication side-effects linked with particular chronic situations, and as an option technique for therapy of discomfort, seizures, and inflammation in this population. Further patient-centered investigation is necessary to determine precise dosing patterns of MC merchandise linked with symptom alleviation and make longitudinal information assessing chronic illness outcomes with MC use.